Why Shares of Illumina Rose 15.3% in January

Shares of genomics leader Illumina (NASDAQ: ILMN) rose 15.3% in January, according to data provided by S&P Global Market Intelligence. Although the genomics leader didn't announce any financial updates during the month, it did win a patent lawsuit.

Furthermore, the identification of new COVID-19 variants overseas using genomics testing drew attention to the importance of genomics overall. The U.S. hadn't used genomics as much, so putting a spotlight on COVID-19 gene sequencing gave another boost to this industry leader.

Image source: Getty Images.

Continue reading

Source Fool.com